Get startedLog in
    Picture of Palvella Therapeutics logo

    PVLA — Palvella Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: Pieris Pharmaceuticals Reports Quarterly Loss Per Share Of $0.13 - Filing

    Picture of Palvella Therapeutics logoPalvella Therapeutics
    02/11/2022 11:57
    Nov 2 (Reuters) - Pieris Pharmaceuticals Inc  PIRS.O :
    * PIERIS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.13
    * PIERIS PHARMACEUTICALS - INCLUDING PROCEEDS FROM
ANTICIPATED
NEAR-TERM MILESTONES, CO BELIEVES OPERATIONS ARE SUFFICIENTLY
FUNDED INTO Q2 2024
    * PIERIS PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS, AND
INVESTMENTS TOTALED $69.8 MILLION FOR QUARTER ENDED SEPTEMBER
30, 2022

Source text for Eikon: [https://bit.ly/3TUcn0i]
Further company coverage:  PIRS.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Palvella Therapeutics

    See all news